— Know what they know.
Not Investment Advice

TAOX NASDAQ

TAO Synergies Inc.
1W: -0.5% 1M: +14.8% 3M: +14.6% YTD: -0.5% 1Y: -30.6%
$4.41
+0.02 (+0.46%)
 
Weekly Expected Move ±11.1%
$3 $4 $4 $5 $5
NASDAQ · Technology · Software - Application · Tech Score Buy · Power 64 · $33.0M mcap · 7M float · 1.92% daily turnover · Short 67% of daily vol
Smart Money Score
Moderate 50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$33.0M
52W Range3.065-10
Volume246,412
Avg Volume139,816
Beta1.50
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJoshua N. Silverman
Employees5
SectorTechnology
IndustrySoftware - Application
IPO Date2025-07-02
1185 Avenue of the Americas, 3rd Floor
New York, NY 10036
US
About TAO Synergies Inc.

TAO Synergies Inc. operates as a biopharmaceutical company currently in the clinical development stage. It is dedicated to advancing a bryostatin-1 therapeutic platform, specifically designed to combat Alzheimer's and various other neurodegenerative and cognitive disorders. Beyond its drug development efforts, the firm is also diversifying its treasury strategy, with a new approach centered on the management of digital assets, primarily focusing on the acquisition and 'staking' of TAO cryptocurrency.

Recent Insider Trades

NameTypeSharesPriceDate
Silverman Joshua A-Award 200,000 $4.80 2026-05-18
Bernstein Bruce A-Award 55,000 $4.80 2026-05-18
Singer William S. A-Award 35,000 $4.80 2026-05-18
WEINSTEIN ROBERT A-Award 30,000 $4.80 2026-05-18
Ephron Robert A-Award 10,000 $4.80 2026-05-18

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms